Search by Drug Name or NDC

    NDC 50804-0006-03 Pressure plus Pain PE plus Mucus 325; 200; 5 mg/1; mg/1; mg/1 Details

    Pressure plus Pain PE plus Mucus 325; 200; 5 mg/1; mg/1; mg/1

    Pressure plus Pain PE plus Mucus is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GoodSense. The primary component is ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 50804-0006
    Product ID 50804-006_e8b846bc-7203-21ef-e053-2995a90a2e55
    Associated GPIs 43996703500310
    GCN Sequence Number 060554
    GCN Sequence Number Description guaifen/phenyleph/acetaminophn TABLET 200-5-325 ORAL
    HIC3 B3N
    HIC3 Description DECONGESTANT-ANALGESIC-EXPECTORANT COMBINATION
    GCN 26743
    HICL Sequence Number 023719
    HICL Sequence Number Description GUAIFENESIN/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Pressure plus Pain PE plus Mucus
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GoodSense
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 50804-0006-03 (50804000603)

    NDC Package Code 50804-006-03
    Billing NDC 50804000603
    Package 2 BLISTER PACK in 1 CARTON (50804-006-03) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2016-05-31
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 4c2613d5-8365-4cc9-951d-8bb2f821cce7 Details

    Revised: 9/2022